Pulse Biosciences names Steven T. Weber as VP Accounting and principal accounting officer

PULSE BIOSCIENCES, INC.

Steven T. Weber appointed VP of Accounting and Global Corporate Controller effective July 14, 2025, succeeding as principal accounting officer.
Weber brings 25+ years of experience; most recently SVP, Corporate Controller and PAO at IGM Biosciences.
Received start-date option for 55,000 shares at $16.03 (July 11 close), with time and performance-based vesting.
Performance vesting tied to market cap milestones: $1.5B, $2.25B, $3.0B, $4.0B sustained for 270 days or by set dates through 2029.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.